HIMS Jan 2025 15.000 put
- Simply Wall St.
Explore These 3 US Growth Companies With High Insider Ownership
The United States stock market has shown robust performance, with a 1.0% increase over the last week and a notable 22% rise over the past year. In this context of promising growth, companies with high insider ownership can be particularly appealing as they often indicate strong confidence from those most familiar with the business.
- Yahoo Finance Video
Nvidia earnings, housing market outlook, BNPL regulatory pressure: Market Domination
On today's episode of Market Domination, Yahoo Finance hosts Julie Hyman and Josh Lipton break down the trading day's biggest stories and latest trends. Nvidia (NVDA) topped earnings expectations and announced a 10-to-1 stock split. Will McGough, Director of Investments at Prime Capital Investment Advisors says the company's AI play "has huge implications across multiple markets." RBC Capital Markets Software Equity Analyst Rishi Jaluria adds, "80% of CIOs are telling us that they are either currently in production or expect to be in production with AI over the next 12 months, so the appetite is real, the use cases are real." Macquarie Head of US AI and Software Research Frederick Havemeyer notes that cybersecurity companies will benefit from the AI race, pointing to CrowdStrike (CRWD), which he believes will see growth as the competition heats up. New housing data reveals that April home sales fell below estimates, declining more than expected: a 1.9% drop month over month. Realtor.com Chief Economist Danielle Hale expects the real estate market and buyer activity to "ramp up" with every mortgage rate dip but forecasts a "slow comeback" overall. Goldman Sachs upgraded Shopify (SHOP) to Buy from Neutral, raising its price target on the stock to $74 from $67. Meanwhile, Citigroup downgraded Hims & Hers Health (HIMS) to Neutral from Buy and raised its price target to $20 from $16. Buy now, pay later (BNPL) stocks (AFRM, PYPL, SQ) are under pressure after the Consumer Financial Protection Bureau proposed a new rule that would force lenders to adhere to the same consumer protections as credit cards. This post was written by Melanie Riehl
- Yahoo Finance Video
Citigroup downgrades Hims & Hers Health to Neutral from Buy
Citigroup has downgraded Hims & Hers Health (HIMS) to Neutral from Buy and raised its price target to $20 from $16. Yahoo Finance's Julie Hyman and Josh Lipton explain how this move is affecting the company's stock valuation. For more expert insight and the latest market action, click here to watch this full episode of Market Domination. This post was written by Melanie Riehl
